Puyjarinet F, Chaix Y, Biotteau M
Children (Basel). 2024; 11(1).
PMID: 38255345
PMC: 10813961.
DOI: 10.3390/children11010031.
Carkaci-Salli N, Bewley M, Tekin I, Flanagan J, Vrana K
Biochem Biophys Rep. 2023; 35:101527.
PMID: 37608910
PMC: 10440358.
DOI: 10.1016/j.bbrep.2023.101527.
Han C, Li R, Hansen E, Trescott S, Fixsen B, Nguyen C
Immunity. 2023; 56(9):2152-2171.e13.
PMID: 37582369
PMC: 10529991.
DOI: 10.1016/j.immuni.2023.07.016.
Gutierrez-Casares J, Segu-Verges C, Sabate Chueca J, Pozo-Rubio T, Coma M, Montoto C
Front Neurosci. 2023; 17:1118253.
PMID: 37457000
PMC: 10347683.
DOI: 10.3389/fnins.2023.1118253.
Bundgaard-Nielsen C, Lauritsen M, Knudsen J, Rold L, Larsen M, Hindersson P
Gut Microbes. 2023; 15(1):2211923.
PMID: 37199526
PMC: 10197996.
DOI: 10.1080/19490976.2023.2211923.
ADHD genetic burden associates with older epigenetic age: mediating roles of education, behavioral and sociodemographic factors among older adults.
Arpawong T, Klopack E, Kim J, Crimmins E
Clin Epigenetics. 2023; 15(1):67.
PMID: 37101297
PMC: 10131361.
DOI: 10.1186/s13148-023-01484-y.
Maternal Epigenetic Dysregulation as a Possible Risk Factor for Neurodevelopmental Disorders.
Lintas C, Cassano I, Azzara A, Stigliano M, Gregorj C, Sacco R
Genes (Basel). 2023; 14(3).
PMID: 36980856
PMC: 10048308.
DOI: 10.3390/genes14030585.
Animal Models of Childhood Exposure to Lead or Manganese: Evidence for Impaired Attention, Impulse Control, and Affect Regulation and Assessment of Potential Therapies.
Smith D, Strupp B
Neurotherapeutics. 2023; 20(1):3-21.
PMID: 36853434
PMC: 10119373.
DOI: 10.1007/s13311-023-01345-9.
Catecholaminergic and cholinergic neuromodulation in autism spectrum disorder: A comparison to attention-deficit hyperactivity disorder.
Koevoet D, Deschamps P, Kenemans J
Front Neurosci. 2023; 16:1078586.
PMID: 36685234
PMC: 9853424.
DOI: 10.3389/fnins.2022.1078586.
Network analysis of 18 attention-deficit/hyperactivity disorder symptoms suggests the importance of "" and "" as central symptoms: Invariance across age, gender, and subtype presentations.
Liu L, Wang Y, Chen W, Gao Y, Li H, Wang Y
Front Psychiatry. 2022; 13:974283.
PMID: 36339870
PMC: 9633674.
DOI: 10.3389/fpsyt.2022.974283.
Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan.
Dutta C, Christov-Moore L, Ombao H, Douglas P
Front Hum Neurosci. 2022; 16:938501.
PMID: 36226261
PMC: 9548548.
DOI: 10.3389/fnhum.2022.938501.
Air pollutants and attention deficit hyperactivity disorder medication administration in elementary schools.
Saadeh R, Jayawardene W, Lohrmann D, Youssefagha A, Allouh M
Biomed Rep. 2022; 17(5):85.
PMID: 36185787
PMC: 9500478.
DOI: 10.3892/br.2022.1568.
Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP.
Tourjman V, Louis-Nascan G, Ahmed G, DuBow A, Cote H, Daly N
Brain Sci. 2022; 12(8).
PMID: 36009086
PMC: 9406006.
DOI: 10.3390/brainsci12081023.
All in the Family? A Systematic Review and Meta-analysis of Parenting and Family Environment as Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children.
Claussen A, Holbrook J, Hutchins H, Robinson L, Bloomfield J, Meng L
Prev Sci. 2022; 25(Suppl 2):249-271.
PMID: 35438451
PMC: 9017071.
DOI: 10.1007/s11121-022-01358-4.
Targeting PI3K by Natural Products: A Potential Therapeutic Strategy for Attention-deficit Hyperactivity Disorder.
Noori T, Sahebgharani M, Sureda A, Sobarzo-Sanchez E, Fakhri S, Shirooie S
Curr Neuropharmacol. 2022; 20(8):1564-1578.
PMID: 35043762
PMC: 9881086.
DOI: 10.2174/1570159X20666220119125040.
Methods to Develop an Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate.
Gutierrez-Casares J, Quintero J, Jorba G, Junet V, Martinez V, Pozo-Rubio T
Front Psychiatry. 2021; 12:741170.
PMID: 34803764
PMC: 8595241.
DOI: 10.3389/fpsyt.2021.741170.
Impulsive and Omission Errors: Potential Temporal Processing Endophenotypes in ADHD.
Acosta-Lopez J, Suarez I, Pineda D, Cervantes-Henriquez M, Martinez-Banfi M, Lozano-Gutierrez S
Brain Sci. 2021; 11(9).
PMID: 34573239
PMC: 8467181.
DOI: 10.3390/brainsci11091218.
The Role of Epigenetics in the Pathogenesis and Potential Treatment of Attention Deficit Hyperactivity Disorder.
Peedicayil J
Curr Neuropharmacol. 2021; 20(9):1642-1650.
PMID: 34544344
PMC: 9881064.
DOI: 10.2174/1570159X19666210920091036.
ADHD Symptoms in Females of Childhood, Adolescent, Reproductive and Menopause Period.
Antoniou E, Rigas N, Orovou E, Papatrechas A, Sarella A
Mater Sociomed. 2021; 33(2):114-118.
PMID: 34483739
PMC: 8385721.
DOI: 10.5455/msm.2021.33.114-118.
Association Between Periconceptional Weight of Maternal Grandmothers and Attention-Deficit/Hyperactivity Disorder in Grandchildren.
Yim G, Roberts A, Ascherio A, Wypij D, Kioumourtzoglou M, Weisskopf M
JAMA Netw Open. 2021; 4(7):e2118824.
PMID: 34323981
PMC: 8322994.
DOI: 10.1001/jamanetworkopen.2021.18824.